LATELLA, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 13.472
EU - Europa 9.539
AS - Asia 5.033
Continente sconosciuto - Info sul continente non disponibili 21
SA - Sud America 18
OC - Oceania 9
AF - Africa 2
Totale 28.094
Nazione #
US - Stati Uniti d'America 13.435
IE - Irlanda 2.706
CN - Cina 2.641
IT - Italia 2.335
TR - Turchia 1.644
DE - Germania 1.037
UA - Ucraina 887
GB - Regno Unito 738
SE - Svezia 655
SG - Singapore 536
FR - Francia 520
FI - Finlandia 454
IN - India 143
CZ - Repubblica Ceca 48
BE - Belgio 38
VN - Vietnam 33
CA - Canada 30
NL - Olanda 27
RU - Federazione Russa 25
EU - Europa 21
BR - Brasile 15
JP - Giappone 13
ES - Italia 10
RO - Romania 9
IL - Israele 8
PL - Polonia 8
AT - Austria 7
BG - Bulgaria 7
CH - Svizzera 6
MX - Messico 5
NZ - Nuova Zelanda 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
DK - Danimarca 3
EE - Estonia 3
IR - Iran 3
HU - Ungheria 2
IM - Isola di Man 2
IQ - Iraq 2
LU - Lussemburgo 2
MT - Malta 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
AR - Argentina 1
BD - Bangladesh 1
BM - Bermuda 1
BT - Bhutan 1
CL - Cile 1
DM - Dominica 1
EC - Ecuador 1
HR - Croazia 1
KR - Corea 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
PK - Pakistan 1
RS - Serbia 1
SC - Seychelles 1
SM - San Marino 1
TW - Taiwan 1
Totale 28.094
Città #
Jacksonville 3.364
Dublin 2.699
Chandler 2.494
Boardman 1.078
Izmir 848
Nanjing 756
San Mateo 643
Wilmington 488
Lawrence 451
Princeton 451
Ashburn 418
Singapore 342
Dearborn 331
New York 314
Beijing 239
Ann Arbor 234
Nanchang 230
Milan 223
Hangzhou 198
L’Aquila 142
Kunming 132
Tianjin 122
Shenyang 121
Verona 109
Seattle 108
Hebei 103
Rome 97
Jiaxing 95
L'aquila 91
Mountain View 88
Jinan 83
Woodbridge 78
Des Moines 75
Ningbo 64
Bremen 63
Changsha 61
Helsinki 61
Norwalk 61
Hefei 57
Zhengzhou 54
Brno 46
Guangzhou 45
Dallas 42
Los Angeles 39
Shanghai 39
Brussels 36
Napoli 33
Munich 32
Berlin 30
Dong Ket 30
Lanzhou 27
Pune 27
Taizhou 25
Changchun 22
Falls Church 19
Pescara 19
Fuzhou 17
Frankfurt am Main 16
Palermo 16
Bari 14
Bologna 14
Mumbai 14
Naples 14
London 13
Wuhan 13
Düsseldorf 12
Fairfield 12
Fremont 12
Toronto 12
Edinburgh 11
Venezia 11
Auburn Hills 10
Nuremberg 10
Phoenix 10
Pisa 10
Tappahannock 10
Catania 9
Houston 9
Stockholm 9
Toritto 9
Cedar Knolls 8
Perugia 8
Philadelphia 8
Scicli 8
Amsterdam 7
Carugate 7
Chengdu 7
Chicago 7
Florence 7
Giove 7
Huskvarna 7
Messina 7
Reggio Calabria 7
Shaoxing 7
Lappeenranta 6
Redmond 6
San Francisco 6
Taranto 6
Tokyo 6
Trieste 6
Totale 18.602
Nome #
Iperplasia follicolare linfatica dell'intestino tenue. 1.705
Efficacia di un nuovo preparato di olio di pesce sulla recidiva del Morbo di Crohn. Giornale di Gastroenterologia 1996;1:158-162 300
Cellular and molecular mechanisms of intestinal fibrosis 230
Effetti del butirrato sui colonociti umani 142
Subtypes of chronic gastritis in patients with coeliac disease before and after gluten-free diet 112
Association between colonic diverticula and colorectal polyps and cancer 109
Lymphocytic gastritis is present in Celiac Disease and improves after gluten-free diet. 102
Non-Celiac Gluten Sensitivity among Patients Perceiving Gluten-Related Symptoms 101
Subtypes of chronic gastritis in patients with celiac disease before and after gluten-free diet 100
Metabolismo dell'epitelio colico e neoplasie colorettali 98
Association between colorectal polyps and colonic diverticulosis 98
PPAR-gamma improves intestinal fibrosis by targeting the EMT-activator ZEB1. 97
Histological healing in ulcerative colitis with mesalazine and its prognostic role 95
Novel PPARgamma modulator GED-0507-34 Levo ameliorates Inflammation driven intestinal fibrosis. 91
Diarree. In: Manuale di Gastroenterologia - UNIGASTRO (Coordinamento Nazionale dei Docenti Universitari di Malattie dell’Apparato Digerente), EGI Editrice, Edizione 2004-2006, Roma, EGI Editrice, 2004:45-55 91
Low HtrA1 expression in patients with long-standing ulcerative colitis and colorectal cancer 91
Malassorbimenti intestinali e reazioni avverse agli alimenti in gravidanza. Giornale di gastroenterologia 2004;9:7-14 90
Role of glycogen synthase kinase-3β and PPAR-γ on epithelial-to-mesenchymal transition in DSS-induced colorectal fibrosis 89
Epithelial-to-Mesenchymal Transition (EMT) in experimental intestinal fibrosis 88
Rapporto del III Congresso Nazionale della Federazione Italiana di Colonproctologia (FICP). 87
Colite acuta dopo colonscopia. Giornale di Gastroenterologia 1997; 2: 88-93 84
Increased proliferation and apoptosis of colonic epithelial cells in dextran sulphate sodium-induced colitis in rats. 84
IgG4-Related Disease Mimicking Crohn’s Disease: A Case Report and Review of Literature 84
Effects of SCFA on human colonocytes. Gastroenterology International 1998;11:76-79 83
Dietary components that counteract the increased risk of colorectal cancer related to red meat consumption 83
Surrogate Fecal Biomarkers in Inflammatory Bowel Disease: Rivals or Complementary Tools of Fecal Calprotectin? 83
Expression of pro-fibrotic and anti-fibrotic molecules in dimethylnitrosamine-induced hepatic fibrosis 82
Survival and causes of death in Italian patients with ulcerative colitis. A GISC nation-wide study. 81
Espressione dell’anidrasi carbonica 1 nella mucosa colica di pazienti con colite ulcerosa. 81
Morbo di Crohn: elettroliti fecali e equilibrio acido-base in rapporto alla sede delle lesioni. 81
Verifica qualitativa del metodo RIA per CEA, GICA e TPA. 80
Mouse Sertoli cells sustain de novo generation of regulatory T cells by triggering the notch pathway through soluble JAGGED1. 79
Trattamento dell'acalasia con iniezione intrasfinterica di tossina botulinica. Giornale di Gastroenterologia 1997; 2: 94-97 79
Clinical course of Crohn's disease first diagnosed at surgery for acute abdomen. 79
Patofisiologia della diarrea cronica. 79
La terapia medica delle emorragie digestive alte. Atti della XI Riunione Scientifica dell'Associazione Chirurghi Regione-Abruzzo, Avezzano (AQ), 27 Aprile 1985:p. 93-97 79
Increased prevalence of Helicobacter pylori in patients with diabetes mellitus 78
Struttura e funzioni dell’intestino tenue. Giornale di gastroenterologia 2002;7:99-106 78
Metabolismo della mucosa colica Atti del Congresso Nazionale delle Malattie Digestive, Firenze 3-7 Dicembre 1994, Firenze, Scientific Press, 1994:p. 355-362 78
Diarree. In:Manuale di Gastroenterologia- UNIGASTRO (Coordinamento Nazionale dei Docenti Universitari di Malattie dell’Apparato Digerente),Edizione 2007-2009, Roma, EGI Editrice, 2007: 58-69 78
Predictive value of the “DICA” endoscopic classification on the outcome of the diverticular disease of the colon: an international study. 78
Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice 77
Acido lattico fecale e diarrea nella colite ulcerosa 77
An Italian prospective multicenter survey on patients suspected of having non-celiac gluten sensitivity. 76
La calprotectina fecale nei pazienti con malattie infiammatorie intestinali. Giornale di Gastroenterologia 2002;7:152-155 76
Nutrizione artificiale. Giornale di Gastroenterologia 2003;8:65-75 76
Electrolyte loss in stools of ulcerative colitis patients. Guidelines for replacement therapy. Ital. J. Gastroenterol. 1987;19:313-316 76
Seeking clues for a positive diagnosis of the irritable bowel syndrome. Eur. J. Clin. Invest. 1987;17:189-193 75
Nutrizione enterale. Giornale di gastroenterologia 2003;8:90-102 75
Endoscopic measurement of colonic pH in ulcerative colitis. 74
Role of nitric oxide in the impairment of circular muscle contractility of distended, uninflamed mid-colon in TNBS-induced acute distal colitis in rats 73
Prevention of colonic fibrosis by Boswellia and Scutellaria extracts in rats with colitis induced by 2,4,5-trinitrobenzene sulphonic acid 73
Anastomotic configuration and mucosal 5-aminosalicylic acid (5-ASA) concentrations in patients with Crohn's Disease: a GISC study 73
Analisi clinica di una combinazione di markers oncologici nel carcinoma colorettale. Chirurgia Generale – General Surgery 1988;IX:453-457 73
Advances in the pathogenesis of inflammatory bowel diseases: Capri 2010 73
Adherence to anti-tumor necrosis factor alpha therapy in inflammatory bowel diseases: an Italian monocentric experience 73
Current management of severe ulcerative colitis. 73
Effetti sistemici nella diarrea del colon irritabile (CI). 72
I salicilati nella terapia delle malattie infiammatorie intestinali. New York, Raven Health Care Communications, 1993 72
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 72
Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC) 71
Significato prognostico del pre-megacolon. 71
Il 5-ASA (ASACOL) previene le recidive post-operatorie del morbo di crohn (MC): risultati dello studio GISC a tre anni di follow-up. 71
Small bowel carcinomas in coeliac or Crohn's disease: Clinico-pathological, molecular, and prognostic features. A study from the small bowel cancer Italian consortium 71
Le IBD alle soglie del 2000. Giornale di Gastroenterologia, 2000,5:129-146 70
Acute colitis following endoscopy: an outbreak of three cases 70
Ulcerative colitis and multiple organ dysfunction syndrome (MODS). 70
Targeted disruption of TGF-/Smad3 signalling confers resistance to intestinal fibrosis. 70
Predictive value of the Diverticular Inflammation and Complication Assessment (DICA) endoscopic classification on the outcome of diverticular disease of the colon: An international study 70
Nanotechnology in the treatment of inflammatory bowel diseases. 70
Consensus Conference. L'opinione dei gastroenterologi e chirurghi italiani sulla terapia medica e chirurgica delle malattie infiammatorie intestinali. 69
Colonoscopic control of uretero-enteric anastomoses in internal urinary diversion. 69
La risposta del colon nell'alcalosi metabolica acuta 69
5-ASA (ASACOL) prevents post-operative recurrence of Crohn's disease (CD) at 3 years of follow-up. 69
Mastocytic enterocolitis: Increase of mast cells in the gastrointestinal tract of patients with chronic diarrhea 69
Electrolyte and acid base imbalance in patients with rectosigmoid bladder. 68
Verifica qualitativa del metodo RIA per tre markers oncologici. Minerva Medica 1987; 78: 463-464 68
Le coliti acute a risoluzione spontanea. Il Gastroenterologo 1988; 4: 28-30 68
Prognostic factors for post-operative recurrence of Crohn's disease 68
Adherence to anti-tumor necrosis factor alpha therapy in inflammatory bowel diseases: Experience from four referral Italian centers 68
Captopril prevents intestinal fibrosis by TGF-1 downregulation in TNBS colitis in rats. 68
Nerd and oesophageal sensitività. 68
Elettroliti fecali ed equilibrio acido-base nel morbo di Crohn. Riv. It. Colonproct. 1982; 1: 251-254 68
Mucosal healing: Mayo 0 vs 1 after 3 years. 68
Redox Imbalance in Intestinal Fibrosis: Beware of the TGFβ-1, ROS, and Nrf2 Connection 68
Multiple organ dysfunction in ulcerative colitis. Am. J. Gastroenterol. 2000;95:1258-1262 68
Can we prevent, reduce or reverse intestinal fibrosis in IBD? 67
Primary cultures of human in colonocytes as a model to study the regulation of mucosal growth and differentiation 67
Captopril prevents intestinal fibrosis by TGF-1 downregulation in TNBS-induced colitis in rats. 67
Acute colitis following colonoscopy 66
Monthly and seasonal birth patterns and the occurrence of Crohn's disease 66
Primary cultures of proliferating and differentiated colonocytes for studies of epithelial biology. 66
A mathematical model to study natural history of crohn’s disease. 66
The prognostic value of histology in ulcerative colitis in clinical remission with mesalazine 66
Le derivazioni urinarie interne: condizioni a rischio di complicanze neoplastiche e metaboliche. 65
Carbonic andhydrase I reduction in colonic mucosa of patients with active ulcerative colitis 65
GED-0507-34 Levo, a novel modulator of PPARgamma as new therapeutic strategy in the treatment of intestinal fibrosis 65
The use of dialysing bags for the determination of faecal electrolytes. 65
Severe ulcerative colitis (UC) may induce Multiple Organ Dysfunction (MOD). 65
Dissecting the role of PPARgamma in intestinal fibrosis: EMT-activator ZEB1 as new molecular target 65
Totale 9.734
Categoria #
all - tutte 105.453
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.453


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.244 0 0 0 118 144 813 763 210 548 101 57 490
2020/20214.078 110 523 84 536 517 111 561 46 503 115 849 123
2021/20222.272 80 289 260 102 117 36 30 184 161 82 195 736
2022/20237.671 564 252 146 708 792 823 7 523 3.469 44 226 117
2023/20242.184 415 116 88 333 134 405 58 327 11 45 87 165
2024/20251.217 152 145 837 83 0 0 0 0 0 0 0 0
Totale 28.420